about
Prevalence of Trichomonas vaginalis by PCR in men attending a primary care urology clinic in South Korea.In vitro activity of N-chlorotaurine (NCT) in combination with NH4Cl against Trichomonas vaginalis.Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications.PCR for diagnosis of male Trichomonas vaginalis infection with chronic prostatitis and urethritisRegulation of surfactant protein D in the rodent prostate.Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunctionMicrobiological etiology of bacterial prostatitis in general hospital and primary care clinic in KoreaDetection of sexually transmitted pathogens in patients with chronic prostatitis/chronic pelvic pain: a prospective clinical study.Comparison of clinical symptoms scored according to the National Institutes of Health chronic prostatitis symptoms index and assessment of antimicrobial treatment in patients with chronic prostatitis syndrome.Signalling pathways associated with IL-6 production and epithelial-mesenchymal transition induction in prostate epithelial cells stimulated with Trichomonas vaginalis.Inflammatory response of a prostate stromal cell line induced by Trichomonas vaginalis.Inflammatory response of prostate epithelial cells to stimulation by Trichomonas vaginalis.Azithromycin: 1.0 or 3.0 gram dose in the treatment of patients with asymptomatic urogenital chlamydial infections.Diagnosis and treatment of chronic prostatitis caused by Chlamydia trachomatis.Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Ureaplasma urealyticum.
P2860
Q34411072-5287DD4D-8033-4945-9AF8-28ABE3898267Q34538799-433246C4-C0FA-44FB-AED7-F01F9A88F328Q34584671-26B74315-920F-446C-B2BB-4C5032BC6FC6Q34976616-9D09E35F-95FE-4C9B-91F8-167611A2F2F9Q36032897-9A8AACB3-BA0D-4818-ABD0-6C3D50AE3637Q36389346-2D2689AE-C2D9-4B59-A10D-0F278335189BQ37085233-A9FB4AF4-2EFC-4290-B966-705D8DCE2DF7Q37270496-E27C250E-8184-41A8-B79C-7DC845B1618EQ37835066-138324CA-1B01-4EF2-A4C4-D4AE48699697Q37855051-164E4C18-7373-4CAD-80AE-AE20220E236AQ38736205-ABC83E0C-5DAF-40C3-B4EA-987BFE21DC4CQ38797613-6B1DC7AC-7A02-4817-B5EE-FAD609CA34DBQ39043131-53B22EB6-0B18-455E-8673-5C03990C533FQ43418394-AD9FB094-5F50-459C-B23F-3A402944845BQ43418866-DEE2E8B4-CE27-4840-9B0D-FAF5A45DC236Q43807331-60005067-147E-4A94-8554-DB658C3791BF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of unusual pathogens in prostatitis syndrome.
@en
The role of unusual pathogens in prostatitis syndrome.
@nl
type
label
The role of unusual pathogens in prostatitis syndrome.
@en
The role of unusual pathogens in prostatitis syndrome.
@nl
prefLabel
The role of unusual pathogens in prostatitis syndrome.
@en
The role of unusual pathogens in prostatitis syndrome.
@nl
P2093
P1476
The role of unusual pathogens in prostatitis syndrome
@en
P2093
Arjana Tambic Andracevic
Ivan Krhen
Leo Markovinovic
Sime Zekan
Slavko Schonwald
Visnja Skerk
Vjeran Cajic
Vladimira Kruzic
P356
10.1016/J.IJANTIMICAG.2004.02.010
P478
24 Suppl 1
P50
P577
2004-09-01T00:00:00Z